Will Morton[email protected]Digital X-RayGenerative AI model validated in chest x-ray studyA group in South Korea has validated a generative AI model that could reduce reading times and increase chest x-ray reporting accuracy.March 11, 2025InterventionalNew embolization agents safe for treating painful joint disordersThree rapidly biodegradable agents used in embolization procedures appear safe and effective for reducing pain in patients with joint disorders.March 10, 2025Radiation Oncology/TherapyConsolidation reigns in radiation oncologySolo practices in radiation oncology dropped significantly between 2015 and 2023 while the number of large practices increased by more than half.March 7, 2025Molecular ImagingHormone therapy linked to tau accumulation in older womenA PET study reveals that women over the age of 70 who took menopausal hormone therapy more than a decade prior have faster brain tau accumulation.March 7, 2025Molecular ImagingAc-225: From nuclear waste to cancer treatmentU.S. Department of Energy (DOE) efforts to dispose of spent nuclear waste left over from the Cold War has turned into a boon for supplies of actinium-225 (Ac-225).March 5, 2025Molecular ImagingFES-PET shows promise staging patients with low-grade breast cancerF-18 fluoroestradiol (FES) PET may improve staging of grade 1 or 2 estrogen receptor-positive breast cancer compared with F-18 FDG-PET.March 4, 2025Molecular ImagingFAPI-PET/CT shows promise in gynecological cancersFibroblast activation protein inhibitor (FAPI) PET/CT appears superior to FDG-PET/CT for imaging gynecological cancers.March 3, 2025CTRadiologists help refute ‘pregnant mummy’ claimRadiologists have weighed in on a reportedly heated dispute in archeology over whether CT scans show that a mummified ancient Egyptian woman was pregnant.March 3, 2025Molecular ImagingECR: PET/MRI highly effective for detecting prostate cancerHybrid PET/MRI scans outperform either technique alone for identifying tumors in high-risk patients with suspected prostate cancer.February 28, 2025CTAI helps predict kidney function decline in Lu-177 patientsAn open-source AI tool can help predict renal function decline in prostate cancer patients undergoing lutetium-177 (Lu-177) radiopharmaceutical therapy.February 25, 2025Previous PagePage 6 of 50Next PageTop StoriesDigital X-RayChest x-rays reveal atherosclerosis in patients undergoing amputationsLower limb amputation is an increasingly common major complication of advanced peripheral arterial disease and diabetes mellitus.MRI3D MRI technique helps plan treatment for pediatric heart conditionsWomens ImagingCould AI scoring help with managing DCIS?CTClinicians, beware: CT diagnostic accuracy varies by adnexal lesion typePractice ManagementRadiology coding update for 2026